Quinuclidinone analogues as anticancer agents
US-2024217964-A1 · Jul 4, 2024 · US
Compounds useful for producing an optically active diazabicyclooctane compound
US9284273B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9284273-B2 |
| Application number | US-201514676179-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 1, 2015 |
| Priority date | Dec 22, 2010 |
| Publication date | Mar 15, 2016 |
| Grant date | Mar 15, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A compound of the following compound (B): wherein tBu represents a tert-butyl group. A compound of the following compound (C): wherein tBu represents a tert-butyl group, and TFA represents a trifluoroacetyl group.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound of the following formula (B): wherein tBu represents a tert-butyl group. 2. A compound of the following formula (C): wherein tBu represents a tert-butyl group, and TFA represents a trifluoroacetyl group.
Assignees
Inventors
Classifications
- C07D471/08Primary
Bridged systems · CPC title
- C07D211/60Primary
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
Optical isomers · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9284273B2 cover?
- A compound of the following compound (B): wherein tBu represents a tert-butyl group. A compound of the following compound (C): wherein tBu represents a tert-butyl group, and TFA represents a trifluoroacetyl group.
- Who is the assignee on this patent?
- Meiji Seika Pharma Co Ltd
- What technology area does this patent fall under?
- Primary CPC classification C07D471/08. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).